Overview

Axitinib + Ipilimumab in Advanced Melanoma

Status:
Recruiting
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
Pfizer
Treatments:
Axitinib
Ipilimumab